HEADER VIRAL PROTEIN 02-AUG-17 5OMZ TITLE SOLUTION STRUCTURE OF DOMAIN III (DIII)OF ZIKA VIRUS ENVELOPE PROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENVELOPE PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: DOMAIN DIII, UNP RESIDUES 585-699; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ZIKA VIRUS (STRAIN MR 766); SOURCE 3 ORGANISM_COMMON: ZIKV; SOURCE 4 ORGANISM_TAXID: 64320; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET21A KEYWDS ZIKA VIRUS ENVELOPE PROTEIN DOMAIN, VIRAL PROTEIN, ZIKV EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR O.ZERBE,M.BARDELLI REVDAT 4 19-JUN-24 5OMZ 1 REMARK REVDAT 3 14-JUN-23 5OMZ 1 REMARK REVDAT 2 08-MAY-19 5OMZ 1 REMARK REVDAT 1 04-OCT-17 5OMZ 0 JRNL AUTH J.WANG,M.BARDELLI,D.A.ESPINOSA,M.PEDOTTI,T.S.NG,S.BIANCHI, JRNL AUTH 2 L.SIMONELLI,E.X.Y.LIM,M.FOGLIERINI,F.ZATTA,S.JACONI, JRNL AUTH 3 M.BELTRAMELLO,E.CAMERONI,G.FIBRIANSAH,J.SHI,T.BARCA, JRNL AUTH 4 I.PAGANI,A.RUBIO,V.BROCCOLI,E.VICENZI,V.GRAHAM,S.PULLAN, JRNL AUTH 5 S.DOWALL,R.HEWSON,S.JURT,O.ZERBE,K.STETTLER,A.LANZAVECCHIA, JRNL AUTH 6 F.SALLUSTO,A.CAVALLI,E.HARRIS,S.M.LOK,L.VARANI,D.CORTI JRNL TITL A HUMAN BI-SPECIFIC ANTIBODY AGAINST ZIKA VIRUS WITH HIGH JRNL TITL 2 THERAPEUTIC POTENTIAL. JRNL REF CELL V. 171 229 2017 JRNL REFN ISSN 1097-4172 JRNL PMID 28938115 JRNL DOI 10.1016/J.CELL.2017.09.002 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA 3.97 REMARK 3 AUTHORS : GUNTERT, MUMENTHALER AND WUTHRICH REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: FURTHER REFINEMENT IN AMBER REMARK 4 REMARK 4 5OMZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-AUG-17. REMARK 100 THE DEPOSITION ID IS D_1200006044. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 300 REMARK 210 PH : 6.0 REMARK 210 IONIC STRENGTH : 0.27 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 800 UM 15N,13C ZIKA ENVELOPE REMARK 210 DIII, 20 MM SODIUM PHOSPHATE, 50 REMARK 210 MM SODIUM CHLORIDE, 90% H2O/10% REMARK 210 D2O; 400 UM 2H,13C,15N ZIKA REMARK 210 ENVELOPE DIII, 20 MM SODIUM REMARK 210 PHOSPHATE, 50 MM SODIUM CHLORIDE, REMARK 210 440 UM ZKA190 FAB, 90% H2O/10% REMARK 210 D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC REMARK 210 ALIPHATIC; 2D 1H-13C HSQC REMARK 210 AROMATIC; 3D HNCO; 3D HN(CA)CO; REMARK 210 3D CBCA(CO)NH; 3D HNCACB; 3D REMARK 210 HCCH-TOCSY; 3D H(C)CH; 3D REMARK 210 HBHA(CO)NH; 3D 1H-15N NOESY; 3D REMARK 210 1H-13C NOESY ALIPHATIC; 3D 1H- REMARK 210 13C NOESY AROMATIC REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 700 MHZ REMARK 210 SPECTROMETER MODEL : AV-4; AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN 2.1, CARA 1.93 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9230 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 10 112.65 -176.15 REMARK 500 1 ASN A 68 73.22 -170.57 REMARK 500 1 THR A 75 171.98 -53.46 REMARK 500 1 PRO A 87 -179.08 -69.79 REMARK 500 1 LYS A 100 34.62 -94.67 REMARK 500 2 ALA A 39 42.24 -95.27 REMARK 500 2 ASP A 42 35.69 -96.22 REMARK 500 2 ALA A 52 121.79 -176.66 REMARK 500 2 PRO A 60 87.89 -69.79 REMARK 500 2 ASN A 68 72.33 -175.42 REMARK 500 2 GLU A 76 179.25 -59.98 REMARK 500 2 PRO A 87 -172.22 -69.72 REMARK 500 2 LYS A 100 34.39 -95.66 REMARK 500 2 HIS A 104 114.82 -163.68 REMARK 500 3 ALA A 39 38.78 -96.90 REMARK 500 3 ASP A 42 107.83 -173.74 REMARK 500 3 ALA A 52 106.99 -171.85 REMARK 500 3 GLU A 76 172.37 -54.51 REMARK 500 3 PRO A 87 -173.22 -69.77 REMARK 500 3 LYS A 100 34.59 -95.04 REMARK 500 3 SER A 109 -179.09 -171.52 REMARK 500 3 ILE A 113 -175.84 -66.42 REMARK 500 4 SER A 10 41.57 -94.98 REMARK 500 4 THR A 15 82.60 -151.47 REMARK 500 4 ALA A 16 -176.95 -62.85 REMARK 500 4 ALA A 39 -68.59 -96.96 REMARK 500 4 ASN A 68 71.85 -178.94 REMARK 500 4 GLU A 76 178.37 -59.34 REMARK 500 4 PRO A 87 -173.88 -69.72 REMARK 500 4 LYS A 100 34.22 -95.78 REMARK 500 4 THR A 112 -57.81 -126.29 REMARK 500 5 LYS A 7 -70.64 -62.51 REMARK 500 5 THR A 41 -39.80 -131.26 REMARK 500 5 ASP A 42 101.52 -161.51 REMARK 500 5 PRO A 87 -170.79 -69.70 REMARK 500 5 LYS A 100 34.37 -95.38 REMARK 500 5 HIS A 105 102.29 -53.51 REMARK 500 6 ALA A 25 127.62 -178.07 REMARK 500 6 THR A 41 34.27 -95.19 REMARK 500 6 ASN A 77 71.41 60.98 REMARK 500 6 PRO A 87 -171.39 -69.72 REMARK 500 6 LYS A 100 35.13 -94.61 REMARK 500 6 LYS A 101 166.37 -49.94 REMARK 500 6 THR A 112 -73.54 -108.98 REMARK 500 7 ALA A 52 -178.77 -173.16 REMARK 500 7 PRO A 60 92.12 -69.80 REMARK 500 7 ASN A 68 73.40 -174.06 REMARK 500 7 THR A 75 172.36 -53.32 REMARK 500 7 LYS A 100 34.24 -95.97 REMARK 500 8 LYS A 3 114.16 -169.38 REMARK 500 REMARK 500 THIS ENTRY HAS 148 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 34167 RELATED DB: BMRB REMARK 900 SOLUTION STRUCTURE OF DOMAIN III (DIII)OF ZIKA VIRUS ENVELOPE REMARK 900 PROTEIN DBREF1 5OMZ A 1 115 UNP A0A1V0E2E5_ZIKV DBREF2 5OMZ A A0A1V0E2E5 585 699 SEQRES 1 A 115 MET ASP LYS LEU ARG LEU LYS GLY VAL SER TYR SER LEU SEQRES 2 A 115 CYS THR ALA ALA PHE THR PHE THR LYS ILE PRO ALA GLU SEQRES 3 A 115 THR LEU HIS GLY THR VAL THR VAL GLU VAL GLN TYR ALA SEQRES 4 A 115 GLY THR ASP GLY PRO CYS LYS VAL PRO ALA GLN MET ALA SEQRES 5 A 115 VAL ASP MET GLN THR LEU THR PRO VAL GLY ARG LEU ILE SEQRES 6 A 115 THR ALA ASN PRO VAL ILE THR GLU SER THR GLU ASN SER SEQRES 7 A 115 LYS MET MET LEU GLU LEU ASP PRO PRO PHE GLY ASP SER SEQRES 8 A 115 TYR ILE VAL ILE GLY VAL GLY GLU LYS LYS ILE THR HIS SEQRES 9 A 115 HIS TRP HIS ARG SER GLY SER THR ILE GLY LYS SHEET 1 AA1 2 PHE A 20 LYS A 22 0 SHEET 2 AA1 2 GLU A 35 VAL A 36 -1 O GLU A 35 N THR A 21 SHEET 1 AA2 2 ARG A 63 LEU A 64 0 SHEET 2 AA2 2 LEU A 84 ASP A 85 -1 N ASP A 85 O ARG A 63 SHEET 1 AA3 2 VAL A 94 ILE A 95 0 SHEET 2 AA3 2 ILE A 102 THR A 103 -1 O ILE A 102 N ILE A 95 CISPEP 1 GLY A 43 PRO A 44 1 0.12 CISPEP 2 GLY A 43 PRO A 44 2 0.02 CISPEP 3 GLY A 43 PRO A 44 3 0.01 CISPEP 4 GLY A 43 PRO A 44 4 -0.02 CISPEP 5 GLY A 43 PRO A 44 5 0.12 CISPEP 6 GLY A 43 PRO A 44 6 0.03 CISPEP 7 GLY A 43 PRO A 44 7 -0.04 CISPEP 8 GLY A 43 PRO A 44 8 0.09 CISPEP 9 GLY A 43 PRO A 44 9 0.14 CISPEP 10 GLY A 43 PRO A 44 10 0.04 CISPEP 11 GLY A 43 PRO A 44 11 -0.06 CISPEP 12 GLY A 43 PRO A 44 12 0.02 CISPEP 13 GLY A 43 PRO A 44 13 0.02 CISPEP 14 GLY A 43 PRO A 44 14 0.08 CISPEP 15 GLY A 43 PRO A 44 15 0.16 CISPEP 16 GLY A 43 PRO A 44 16 0.12 CISPEP 17 GLY A 43 PRO A 44 17 -0.16 CISPEP 18 GLY A 43 PRO A 44 18 0.00 CISPEP 19 GLY A 43 PRO A 44 19 -0.08 CISPEP 20 GLY A 43 PRO A 44 20 0.11 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1